Filing Flows › Gossamer Bio (GOSS) › Next earnings date
Gossamer Bio (GOSS) earnings on Nov 10, 2026: what to expect
Gossamer Bio (GOSS) is expected to report earnings on Nov 10, 2026 (estimated), in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$3.93 (−$7.43 to $0.80, 5 estimates) on revenue of $12.2M, against −$16.80 and $13.3M a year ago. It beat the EPS estimate in 25% of the quarters on record; Filing Flows' model gives it a 51% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$16.80 on revenue of $17.2M, against the analysts' −$3.93.
The last report
Gossamer Bio reported revenue of $9.2M for the second quarter 2026 (-20% Y/Y), net earnings $16.9M. How it makes money → · Every quarter →
Gossamer Bio's latest quarter
Gossamer Bio, Q2 2026: revenue $9.2M (-20% year over year), operating margin -282.2%, net earnings $16.9M, operating cash flow −$39.4M. The chart follows the revenue to costs, profit and cash.
Questions
When does GOSS report earnings?
Gossamer Bio is expected to report on Nov 10, 2026 (estimated).
What are analysts expecting from Gossamer Bio?
EPS of −$3.93 and revenue of $12.2M for the quarter.
Does Gossamer Bio usually beat earnings?
It beat the consensus EPS estimate in 25% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.